Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-11-19 16:18:16
Reporting Period:
Accepted Time:
2019-11-19 16:18:16
Original Submission Date:
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 200028718
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374256 Jr S Richard Eiswirth 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-14 75,000 $0.30 438,901 No 4 P Direct
Common Stock Acquisiton 2019-11-14 25,000 $0.30 463,901 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
  1. Represents shares of common stock that were acquired by the reporting person on the open market. Actual purchase prices ranged from $0.2910 to $0.3030.
  2. Reporting person's original Form 4 mistakenly reported Transaction Code "A".
  3. On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split. The amounts shown in Table I above reflect the amounts reported on the original Form 4. As of the date that this Form 4/A is filed, taking the reverse stock split into account, the amount shown in column 5 would be 30,926 shares.
  4. Ownership is in the name of RICHARD S EISWIRTH, JR IRA SEP.